4//SEC Filing
HALOZYME THERAPEUTICS INC 4
Accession 0001179110-17-006699
$HALOCIK 0001159036operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:56 PM ET
Size
4.8 KB
Accession
0001179110-17-006699
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Award
Common Stock
2017-05-04+14,135→ 202,388 total
Footnotes (1)
- [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders.
Documents
Issuer
HALOZYME THERAPEUTICS INC
CIK 0001159036
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001159036
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:56 PM ET
- Size
- 4.8 KB